Phase 2 Multiple System Atrophy Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
Multiple System Atrophy
Dasher Neuroscience Inc.75 enrolled9 locationsNCT06848231
Recruiting
Phase 2
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
Multiple System Atrophy
Teva Branded Pharmaceutical Products R&D LLC200 enrolled15 locationsNCT07197866
Recruiting
Phase 2
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
Multiple System Atrophy
Teva Branded Pharmaceutical Products R&D LLC350 enrolled54 locationsNCT06568237
Recruiting
Phase 1Phase 2
Automated Abdominal Binder for Orthostatic Hypotension
Multiple System AtrophyAutonomic FailurePure Autonomic Failure+1 more
Vanderbilt University Medical Center31 enrolled1 locationNCT03482297
Recruiting
Phase 2
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
Multiple System Atrophy
Tiziana Life Sciences LTD5 enrolled1 locationNCT06868628
Recruiting
Phase 2Phase 3
[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD
Alzheimer DiseaseParkinson DiseaseDementia With Lewy Bodies+1 more
prof. dr. Koen Van Laere113 enrolled2 locationsNCT06120049
Recruiting
Phase 2
The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism
Multiple System AtrophyCorticobasal SyndromeProgressive Supranuclear Palsy
Haukeland University Hospital330 enrolled3 locationsNCT06162013